- Home
- KNSA vs UVV Comparison
KNSA vs UVV Comparison
Compare KNSA & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- UVV
- Stock Information
- Founded
- KNSA 2015
- UVV 1886
- Country
- KNSA United Kingdom
- UVV United States
- Employees
- KNSA N/A
- UVV N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- UVV Farming/Seeds/Milling
- Sector
- KNSA Health Care
- UVV Industrials
- Exchange
- KNSA Nasdaq
- UVV Nasdaq
- Market Cap
- KNSA 1.7B
- UVV 1.4B
- IPO Year
- KNSA 2018
- UVV N/A
- Fundamental
- Price
- KNSA $20.59
- UVV $54.68
- Analyst Decision
- KNSA Strong Buy
- UVV
- Analyst Count
- KNSA 5
- UVV 0
- Target Price
- KNSA $36.60
- UVV N/A
- AVG Volume (30 Days)
- KNSA 290.2K
- UVV 161.3K
- Earning Date
- KNSA 10-29-2024
- UVV 02-05-2025
- Dividend Yield
- KNSA N/A
- UVV 5.93%
- EPS Growth
- KNSA N/A
- UVV 5.05
- EPS
- KNSA N/A
- UVV 4.86
- Revenue
- KNSA $384,098,000.00
- UVV $2,827,901,000.00
- Revenue This Year
- KNSA $60.05
- UVV N/A
- Revenue Next Year
- KNSA $36.32
- UVV N/A
- P/E Ratio
- KNSA N/A
- UVV $11.24
- Revenue Growth
- KNSA 54.41
- UVV 6.40
- 52 Week Low
- KNSA $16.56
- UVV $45.19
- 52 Week High
- KNSA $28.15
- UVV $67.80
- Technical
- Relative Strength Index (RSI)
- KNSA 40.95
- UVV 45.09
- Support Level
- KNSA $19.97
- UVV $55.58
- Resistance Level
- KNSA $20.85
- UVV $57.68
- Average True Range (ATR)
- KNSA 0.69
- UVV 1.29
- MACD
- KNSA 0.03
- UVV -0.41
- Stochastic Oscillator
- KNSA 35.61
- UVV 27.54
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.